A possible genetic defect in 25-hydroxylation as a cause of rickets

SJ Casella, BJ Reiner, TC Chen, MF Holick… - The Journal of …, 1994 - Elsevier
SJ Casella, BJ Reiner, TC Chen, MF Holick, HE Harrison
The Journal of pediatrics, 1994Elsevier
We examined two siblings who had severe rickets at ages 2 and 7 years, respectively,
despite a history of adequate vitamin D intake. The patients' sera had calcium
concentrations at the lower limits of normal, low phosphate concentrations, elevated alkaline
phosphatase activity, and low levels of 25-hydroxyvitamin D. Treatment with high doses of
vitamin D 2 resulted in resolution of the biochemical abnormalities and radiographic
deformities; pharmacologic doses of vitamin D 2 were required to maintain normal …
We examined two siblings who had severe rickets at ages 2 and 7 years, respectively, despite a history of adequate vitamin D intake. The patients' sera had calcium concentrations at the lower limits of normal, low phosphate concentrations, elevated alkaline phosphatase activity, and low levels of 25-hydroxyvitamin D. Treatment with high doses of vitamin D2 resulted in resolution of the biochemical abnormalities and radiographic deformities; pharmacologic doses of vitamin D2 were required to maintain normal concentrations of 25-hydroxyvitamin D in the serum even though vitamin D absorption was normal. These children may have a genetic defect of the 25-hydroxylation step in vitamin D activation.
Elsevier